Channel Therapeutics Corporation (PTHS) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Channel Therapeutics Corp...

    NYSE: PTHS · Real-Time Price · USD
    32.55
    0.55 (1.72%)
    At close: Sep 12, 2025, 3:58 PM
    32.88
    1.01%
    After-hours: Sep 12, 2025, 06:00 PM EDT

    Channel Therapeutics Income Statement

    Financials in USD. Fiscal year is undefined.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 n/a n/a n/a n/a
    Gross Profit
    		 n/a n/a n/a n/a
    Operating Income
    		 -7.57M -6.86M -2.32M -839K
    Interest Income
    		 n/a n/a n/a n/a
    Pretax Income
    		 -7.96M -7.38M -2.46M -595.39K
    Net Income
    		 -7.96M -7.38M -2.46M -595.39K
    Selling & General & Admin
    		 6.39M 4.28M 1.93M 629.95K
    Research & Development
    		 1.18M 2.58M 391.73K 209.05K
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 7.57M 6.86M 2.32M 839K
    Interest Expense
    		 786.39K 518.51K 140.43K 253.00
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 7.57M 6.86M 2.32M 839K
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 587.62K 576.75K 576.75K 576.75K
    Shares Outstanding (Diluted)
    		 587.62K 576.75K 576.75K 576.75K
    EPS (Basic)
    		 -13.54 -12.8 -4.26 -1
    EPS (Diluted)
    		 -13.54 -12.8 -4.26 -1
    EBITDA
    		 -7.17M -6.86M -2.32M -595.13K
    EBIT
    		 -7.17M -6.86M -2.32M -595.13K
    Depreciation & Amortization
    		 n/a n/a n/a n/a

    Add to Watchlist